Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Rupa R Patel, Stephen Y Liang, Pooja Koolwal & Frederick Matthew Kuhlmann. (2015) Travel advice for the immunocompromised traveler: prophylaxis, vaccination, and other preventive measures. Therapeutics and Clinical Risk Management 11, pages 217-228.
Read now
Read now
Pascale Cottin, Matthias Niedrig & Cristina Domingo. (2013) Safety profile of the yellow fever vaccine Stamaril®: a 17-year review. Expert Review of Vaccines 12:11, pages 1351-1368.
Read now
Read now
Thomas P Monath. (2012) Review of the risks and benefits of yellow fever vaccination including some new analyses. Expert Review of Vaccines 11:4, pages 427-448.
Read now
Read now
Articles from other publishers (26)
Parikshit Tyagi, Milan Ganguly, Satyaprasad Manney, Kuntinath Wadkar, Nilesh Ingle, Sunil Gairola, Rajeev Dhere, Fusataka Koide & Sheila Grimes. (2023) Neurovirulence, viscerotropism and immunogenicity of live attenuated yellow fever 17D vaccine virus in non-human primates. Vaccine 41:3, pages 836-843.
Crossref
Crossref
J. Erin Staples, Emily H. Davis, Thomas P. Monath & Alan D.T. Barrett. 2023. Plotkin's Vaccines. Plotkin's Vaccines
1251
1321.e19
.
Ana Beatriz Ayroza Galvão Ribeiro Gomes, Lucas Bueno Feo, Guilherme Diogo Silva, Caio César Diniz Disserol, Renata Barbosa Paolilo, Amanda Nazareth Lara, Adriana Coracini Tonácio, Maria Fernanda Mendes, Samira Luísa Apóstolos Pereira & Dagoberto Callegaro. (2022) Reducing infection risk in multiple sclerosis and neuromyelitis optica spectrum disorders: a Brazilian reference center's approach. Arquivos de Neuro-Psiquiatria 80:10, pages 1057-1066.
Crossref
Crossref
Rong Zhao, Meiyue Wang, Jing Cao, Jing Shen, Xin Zhou, Deping Wang & Jimin Cao. (2021) Flavivirus: From Structure to Therapeutics Development. Life 11:7, pages 615.
Crossref
Crossref
Parikshit Tyagi, Milan Ganguly, Satyaprasad Manney, Kuntinath Wadkar, Nilesh Ingle, Sunil Gairola, Rajeev Dhere, Fusataka Koide & Sheila Grimes. (2021) Neurovirulence, Viscerotropism and Immunogenicity of Live Attenuated Yellow Fever 17D Vaccine Virus in Non-Human Primates. SSRN Electronic Journal.
Crossref
Crossref
J. Erin Staples, Alan D. T. Barrett, Annelies Wilder-Smith & Joachim Hombach. (2020) Review of data and knowledge gaps regarding yellow fever vaccine-induced immunity and duration of protection. npj Vaccines 5:1.
Crossref
Crossref
Angela HuttnerGilles Eperon, Agustina M. LascanoSerge RothJean-Marc SchwobClaire-Anne SiegristPatrice H. Lalive. (2020) Risk of MS relapse after yellow fever vaccination. Neurology Neuroimmunology & Neuroinflammation 7:4.
Crossref
Crossref
Robert T. Chen, Jason M. Glanz & Tom T. Shimabukuro. 2019. Pharmacoepidemiology. Pharmacoepidemiology
437
495
.
Stephanie Fischinger, Carolyn M. Boudreau, Audrey L. Butler, Hendrik Streeck & Galit Alter. (2018) Sex differences in vaccine-induced humoral immunity. Seminars in Immunopathology 41:2, pages 239-249.
Crossref
Crossref
Cristiane Pinheiro Pestana, Rafael Lawson-Ferreira, Carolina Lessa-Aquino, Maria da Luz Fernandes Leal, Marcos da Silva Freire, Akira Homma & Marco Alberto Medeiros. (2018) Sanger-based sequencing technology for yellow fever vaccine genetic quality control. Journal of Virological Methods 260, pages 82-87.
Crossref
Crossref
Maud Salmona, Sandrine Gazaignes, Severine Mercier-Delarue, Fabienne Garnier, Jehanara Korimbocus, Nathalie Colin de Verdière, Jerome LeGoff, Pierre Roques & François Simon. (2015) Molecular characterization of the 17D-204 yellow fever vaccine. Vaccine 33:41, pages 5432-5436.
Crossref
Crossref
S. L. Klein, I. Marriott & E. N. Fish. (2015) Sex-based differences in immune function and responses to vaccination. Transactions of the Royal Society of Tropical Medicine and Hygiene 109:1, pages 9-15.
Crossref
Crossref
Camille Escadafal, Oumar Faye, Amadou Alpha Sall, Ousmane Faye, Manfred Weidmann, Oliver Strohmeier, Felix von Stetten, Josef Drexler, Michael Eberhard, Matthias Niedrig & Pranav Patel. (2014) Rapid Molecular Assays for the Detection of Yellow Fever Virus in Low-Resource Settings. PLoS Neglected Tropical Diseases 8:3, pages e2730.
Crossref
Crossref
Ana Cristina Vanderley Oliveira, Licia Maria Henrique da Mota, Leopoldo Luiz dos Santos-Neto, Jozélio Freire De Carvalho, Iramaya Rodrigues Caldas, Olindo Assis Martins Filho & Pedro Luis Tauil. (2014) Occurrence of Autoimmune Diseases Related to the Vaccine against Yellow Fever. Autoimmune Diseases 2014, pages 1-8.
Crossref
Crossref
J.G. Breugelmans, R.F. Lewis, E. Agbenu, O. Veit, D. Jackson, C. Domingo, M. Böthe, W. Perea, M. Niedrig, B.D. Gessner & S. Yactayo. (2013) Adverse events following yellow fever preventive vaccination campaigns in eight African countries from 2007 to 2010. Vaccine 31:14, pages 1819-1829.
Crossref
Crossref
K. Rutkowski, P.W. Ewan & S.M. Nasser. (2013) Administration of Yellow Fever Vaccine in Patients with Egg Allergy. International Archives of Allergy and Immunology 161:3, pages 274-278.
Crossref
Crossref
Mariam Sidibe, Sergio Yactayo, Abdoulaye Kalle, Amadou A. Sall, Samba Sow, Modjirom Ndoutabe, William Perea, Fenella Avokey, Rosamund F. Lewis & Olivia Veit. (2012) Immunogenicity and safety of yellow fever vaccine among 115 HIV-infected patients after a preventive immunisation campaign in Mali. Transactions of the Royal Society of Tropical Medicine and Hygiene 106:7, pages 437-444.
Crossref
Crossref
Robert T. Chen, Jason M. Glanz & Claudia Vellozzi. 2012. Pharmacoepidemiology. Pharmacoepidemiology
423
468
.
Patrice Bourée, Francine Bisaro, Sophie Delaigue, Nagiro Djibo & Paula Resende. (2011) Le diagnostic de la fièvre jaune. Revue Francophone des Laboratoires 2011:430, pages 27-32.
Crossref
Crossref
Malcolm S. Duthie, Hillarie Plessner Windish, Christopher B. Fox & Steven G. Reed. (2011) Use of defined TLR ligands as adjuvants within human vaccines. Immunological Reviews 239:1, pages 178-196.
Crossref
Crossref
Scott B. Halstead. 2011. Nelson Textbook of Pediatrics. Nelson Textbook of Pediatrics
1150
1150.e3
.
Brett M. Forshey, Carolina Guevara, V. Alberto Laguna-Torres, Manuel Cespedes, Jorge Vargas, Alberto Gianella, Efrain Vallejo, C?sar Madrid, Nicolas Aguayo, Eduardo Gotuzzo, Victor Suarez, Ana Maria Morales, Luis Beingolea, Nora Reyes, Juan Perez, Monica Negrete, Claudio Rocha, Amy C. Morrison, Kevin L. Russell, Patrick J. Blair, James G. Olson & Tadeusz J. Kochel. (2010) Arboviral Etiologies of Acute Febrile Illnesses in Western South America, 2000?2007. PLoS Neglected Tropical Diseases 4:8, pages e787.
Crossref
Crossref
Justin G. Julander, Ashok K. Jha, Jung-Ae Choi, Kie-Hoon Jung, Donald F. Smee, John D. Morrey & Chung K. Chu. (2010) Efficacy of 2′-C-methylcytidine against yellow fever virus in cell culture and in a hamster model. Antiviral Research 86:3, pages 261-267.
Crossref
Crossref
Sabra L Klein, Anne Jedlicka & Andrew Pekosz. (2010) The Xs and Y of immune responses to viral vaccines. The Lancet Infectious Diseases 10:5, pages 338-349.
Crossref
Crossref
Olivia VeitChristoph Hatz, Matthias Niedrig & Hansjakob Furrer. (2010) Yellow fever vaccination in HIV-infected patients. HIV Therapy 4:1, pages 17-26.
Crossref
Crossref
Gavin C. Bowick & Alan D. T. Barrett. (2010) Comparative Pathogenesis and Systems Biology for Biodefense Virus Vaccine Development. Journal of Biomedicine and Biotechnology 2010, pages 1-11.
Crossref
Crossref